AstraZeneca News and Research

RSS
Aptamer Group and AstraZeneca to develop new drug delivery vehicles

Aptamer Group and AstraZeneca to develop new drug delivery vehicles

New anti-Wolbachia drug could potentially treat onchocerciasis and lymphatic filariasis

New anti-Wolbachia drug could potentially treat onchocerciasis and lymphatic filariasis

Researchers develop new method of analysis to map cellular locations of proteins

Researchers develop new method of analysis to map cellular locations of proteins

Researchers launch clinical trial to develop breath test for multiple cancers

Researchers launch clinical trial to develop breath test for multiple cancers

Genetic testing can help personalize diagnosis and treatment of kidney disease, study shows

Genetic testing can help personalize diagnosis and treatment of kidney disease, study shows

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Multicolor Immunohistochemistry (IHC): Going Beyond a Single Color

Multicolor Immunohistochemistry (IHC): Going Beyond a Single Color

Cancer Research UK and AstraZeneca open new Functional Genomics Centre

Cancer Research UK and AstraZeneca open new Functional Genomics Centre

Researchers explore why and how Mediterranean diet may mitigate cardiovascular risk

Researchers explore why and how Mediterranean diet may mitigate cardiovascular risk

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

New therapeutic strategy is emerging for type 2 diabetes

New therapeutic strategy is emerging for type 2 diabetes

New breakthrough may speed up research and drug trials to tackle motor neurone disease

New breakthrough may speed up research and drug trials to tackle motor neurone disease

Owlstone Medical named Medtech Company of the Year

Owlstone Medical named Medtech Company of the Year

New inhibitor could hold key to treating Acute Respiratory Distress Syndrome

New inhibitor could hold key to treating Acute Respiratory Distress Syndrome

Diabetes medication reduces risk of heart failure hospitalization

Diabetes medication reduces risk of heart failure hospitalization

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Presence of rare mutations indicates increased risk from interval breast cancers

Presence of rare mutations indicates increased risk from interval breast cancers

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy